The authors aimed to assess whether axillary radiotherapy provides comparable regional control with fewer side–effects. Axillary lymph node dissection and axillary radiotherapy after a positive sentinel node provide excellent and comparable axillary control for patients with T1—2 primary breast cancer and no palpable lymphadenopathy. Axillary radiotherapy results in significantly less morbidity.

READ FULL ARTICLE Curated publisher From Mdlinx